港交所谴责复宏汉霖擅改上市募资用途;华检医疗收购国富量子20.3%股权丨港交所早参

每日经济新闻
Sep 03, 2025

NO.1港交所谴责复宏汉霖擅改上市募资用途  9月2日,港交所发布公告,谴责复宏汉霖(02696.HK,股价80.8港元)及批评其前执行董事兼首席执行官刘世高,并指令刘世高完成培训。该公司被裁定于上市首日(2019年9月25日)订立投资管理协议,委聘尚乘环球市场有限公司为其资产管理人、代理人及受托人,以代表该公司投资1.17亿美元,投资金额全数来自该公司首次公开招股的集资额。港交所表示,上述...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10